Nivolumab in patients with advanced renal cell carcinoma in France: interim results of the observational, real-world WITNESS study
-
Published:2024-07
Issue:7
Volume:9
Page:103602
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Barthélémy P.,
Albigès L.,
Escudier B.,
Narciso B.,
Bigot P.ORCID,
Chehimi M.,
Emambux S.ORCID,
Calcagno F.ORCID,
Mouillet G.,
Eymard J.-C.,
Schlürmann F.,
Bailly S.,
Garbay D.,
Berdah J.-F.,
Palmaro M.B.,
Goupil M.G.ORCID,
Spaeth D.ORCID,
Néré S.,
Quentric C.,
Vano Y.-A.ORCID,
Thiery-Vuillemin A.
Funder
Bristol-Myers Squibb